Jeremy Prager
Concepts (436)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trachea | 14 | 2026 | 253 | 3.460 |
Why?
| | Tracheal Stenosis | 7 | 2026 | 38 | 2.380 |
Why?
| | Tonsillectomy | 6 | 2025 | 106 | 2.160 |
Why?
| | Otolaryngology | 7 | 2022 | 106 | 1.780 |
Why?
| | Laryngoscopy | 8 | 2024 | 122 | 1.560 |
Why?
| | Bronchoscopy | 13 | 2026 | 227 | 1.540 |
Why?
| | Respiratory Tract Diseases | 4 | 2019 | 178 | 1.510 |
Why?
| | Deglutition Disorders | 6 | 2026 | 159 | 1.320 |
Why?
| | Larynx | 4 | 2024 | 56 | 1.190 |
Why?
| | Tracheomalacia | 4 | 2022 | 16 | 1.140 |
Why?
| | Correspondence as Topic | 3 | 2012 | 16 | 1.040 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2025 | 23 | 0.910 |
Why?
| | Laryngostenosis | 3 | 2023 | 54 | 0.900 |
Why?
| | Papilloma | 1 | 2025 | 17 | 0.890 |
Why?
| | Respiratory Distress Syndrome, Newborn | 2 | 2018 | 104 | 0.880 |
Why?
| | Antiemetics | 1 | 2025 | 51 | 0.870 |
Why?
| | Child | 58 | 2026 | 22638 | 0.870 |
Why?
| | Otitis Media | 7 | 2023 | 178 | 0.860 |
Why?
| | Oropharyngeal Neoplasms | 1 | 2025 | 56 | 0.860 |
Why?
| | Mouth Neoplasms | 1 | 2025 | 90 | 0.840 |
Why?
| | Airway Obstruction | 6 | 2021 | 152 | 0.820 |
Why?
| | Bronchi | 1 | 2026 | 263 | 0.810 |
Why?
| | Papillomavirus Infections | 3 | 2025 | 345 | 0.790 |
Why?
| | Tomography, Optical Coherence | 1 | 2026 | 277 | 0.790 |
Why?
| | Esophagoscopy | 4 | 2020 | 223 | 0.770 |
Why?
| | Dexamethasone | 1 | 2025 | 368 | 0.760 |
Why?
| | Efficiency, Organizational | 4 | 2019 | 142 | 0.760 |
Why?
| | Operating Rooms | 2 | 2015 | 144 | 0.730 |
Why?
| | Gastrointestinal Diseases | 3 | 2019 | 220 | 0.730 |
Why?
| | Tracheostomy | 3 | 2025 | 136 | 0.730 |
Why?
| | Otorhinolaryngologic Surgical Procedures | 3 | 2021 | 38 | 0.700 |
Why?
| | Adenoidectomy | 4 | 2021 | 82 | 0.680 |
Why?
| | Otorhinolaryngologic Diseases | 2 | 2019 | 17 | 0.680 |
Why?
| | Polytetrafluoroethylene | 1 | 2021 | 24 | 0.680 |
Why?
| | Respiratory Sounds | 2 | 2018 | 102 | 0.660 |
Why?
| | Child, Preschool | 36 | 2026 | 11888 | 0.660 |
Why?
| | Abscess | 1 | 2020 | 77 | 0.620 |
Why?
| | Ancillary Services, Hospital | 1 | 2019 | 2 | 0.600 |
Why?
| | Congenital Abnormalities | 2 | 2024 | 108 | 0.590 |
Why?
| | Infant | 27 | 2026 | 10093 | 0.580 |
Why?
| | Hematologic Neoplasms | 1 | 2021 | 169 | 0.580 |
Why?
| | Hospitals, Pediatric | 6 | 2020 | 561 | 0.580 |
Why?
| | Humans | 90 | 2026 | 145625 | 0.580 |
Why?
| | Digestive System Diseases | 1 | 2019 | 28 | 0.580 |
Why?
| | Helicobacter Infections | 1 | 2018 | 30 | 0.560 |
Why?
| | Internship and Residency | 4 | 2020 | 1269 | 0.560 |
Why?
| | Helicobacter pylori | 1 | 2018 | 44 | 0.560 |
Why?
| | Craniocerebral Trauma | 1 | 2020 | 173 | 0.550 |
Why?
| | Patient Care Team | 3 | 2019 | 700 | 0.550 |
Why?
| | Tracheal Neoplasms | 1 | 2018 | 11 | 0.540 |
Why?
| | Eosinophilic Esophagitis | 3 | 2019 | 333 | 0.530 |
Why?
| | Retrospective Studies | 26 | 2026 | 17291 | 0.520 |
Why?
| | Intubation, Intratracheal | 3 | 2015 | 328 | 0.520 |
Why?
| | Male | 51 | 2026 | 73014 | 0.500 |
Why?
| | Paraganglioma | 1 | 2018 | 65 | 0.500 |
Why?
| | Gastroesophageal Reflux | 4 | 2023 | 232 | 0.460 |
Why?
| | Quality Improvement | 3 | 2016 | 1325 | 0.460 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2019 | 304 | 0.450 |
Why?
| | Tracheoesophageal Fistula | 3 | 2022 | 38 | 0.440 |
Why?
| | Natural Orifice Endoscopic Surgery | 1 | 2015 | 34 | 0.440 |
Why?
| | Female | 47 | 2026 | 79080 | 0.430 |
Why?
| | Patient Satisfaction | 2 | 2019 | 698 | 0.430 |
Why?
| | Gastroenterology | 3 | 2023 | 185 | 0.430 |
Why?
| | Spinal Fractures | 1 | 2015 | 81 | 0.430 |
Why?
| | Phenol | 1 | 2014 | 15 | 0.420 |
Why?
| | Drug Labeling | 1 | 2014 | 36 | 0.420 |
Why?
| | Clinical Competence | 4 | 2020 | 1261 | 0.420 |
Why?
| | Burns, Chemical | 1 | 2014 | 32 | 0.410 |
Why?
| | Anti-Infective Agents, Local | 1 | 2014 | 40 | 0.410 |
Why?
| | Delphi Technique | 8 | 2024 | 347 | 0.400 |
Why?
| | Medical Audit | 1 | 2014 | 77 | 0.400 |
Why?
| | Chromosome Disorders | 1 | 2013 | 46 | 0.390 |
Why?
| | Postoperative Complications | 6 | 2022 | 2962 | 0.380 |
Why?
| | Career Choice | 2 | 2011 | 235 | 0.370 |
Why?
| | Thyroid Neoplasms | 3 | 2023 | 380 | 0.370 |
Why?
| | Adolescent | 27 | 2026 | 22451 | 0.360 |
Why?
| | Wounds, Nonpenetrating | 1 | 2015 | 304 | 0.360 |
Why?
| | Abnormalities, Multiple | 1 | 2013 | 193 | 0.350 |
Why?
| | Sleep Apnea Syndromes | 1 | 2013 | 98 | 0.350 |
Why?
| | Student Dropouts | 1 | 2011 | 8 | 0.340 |
Why?
| | Writing | 1 | 2012 | 101 | 0.330 |
Why?
| | Deafness | 1 | 2012 | 67 | 0.330 |
Why?
| | Job Description | 1 | 2010 | 10 | 0.330 |
Why?
| | Cochlear Implantation | 1 | 2012 | 74 | 0.330 |
Why?
| | Pharyngeal Diseases | 1 | 2010 | 17 | 0.320 |
Why?
| | Endoscopy, Gastrointestinal | 2 | 2024 | 236 | 0.320 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2012 | 192 | 0.320 |
Why?
| | Education, Medical, Continuing | 1 | 2011 | 130 | 0.320 |
Why?
| | Pediatrics | 4 | 2019 | 1122 | 0.310 |
Why?
| | Pulmonary Embolism | 1 | 2013 | 245 | 0.310 |
Why?
| | Fucosyltransferases | 2 | 2022 | 31 | 0.310 |
Why?
| | Bronchiectasis | 3 | 2020 | 115 | 0.310 |
Why?
| | School Admission Criteria | 1 | 2010 | 35 | 0.310 |
Why?
| | Intestinal Mucosa | 1 | 2015 | 666 | 0.300 |
Why?
| | Tracheotomy | 4 | 2019 | 23 | 0.290 |
Why?
| | Personnel Selection | 1 | 2010 | 90 | 0.290 |
Why?
| | Microbiota | 5 | 2023 | 724 | 0.290 |
Why?
| | Palatine Tonsil | 2 | 2021 | 55 | 0.280 |
Why?
| | Thoracoscopy | 2 | 2019 | 60 | 0.280 |
Why?
| | Esophageal Atresia | 2 | 2020 | 32 | 0.270 |
Why?
| | Infant, Newborn | 8 | 2023 | 6449 | 0.270 |
Why?
| | Hearing Loss, Conductive | 1 | 2007 | 24 | 0.260 |
Why?
| | Faculty, Medical | 1 | 2010 | 305 | 0.250 |
Why?
| | Anesthesia | 2 | 2023 | 257 | 0.250 |
Why?
| | Craniosynostoses | 1 | 2007 | 69 | 0.250 |
Why?
| | Program Development | 2 | 2019 | 365 | 0.240 |
Why?
| | Ear, Middle | 5 | 2023 | 78 | 0.240 |
Why?
| | Deglutition | 2 | 2024 | 73 | 0.240 |
Why?
| | Treatment Outcome | 9 | 2024 | 11744 | 0.230 |
Why?
| | Mandibular Fractures | 1 | 2026 | 16 | 0.230 |
Why?
| | Surgeons | 2 | 2020 | 337 | 0.220 |
Why?
| | Down Syndrome | 2 | 2023 | 529 | 0.220 |
Why?
| | Biopsy | 3 | 2019 | 1073 | 0.220 |
Why?
| | Tracheobronchomalacia | 2 | 2022 | 14 | 0.220 |
Why?
| | Practice Guidelines as Topic | 2 | 2018 | 1581 | 0.220 |
Why?
| | Administration, Intravenous | 1 | 2025 | 172 | 0.210 |
Why?
| | Papillomaviridae | 1 | 2025 | 113 | 0.210 |
Why?
| | Nasal Septal Perforation | 1 | 2024 | 5 | 0.210 |
Why?
| | Respiratory Tract Infections | 3 | 2021 | 399 | 0.210 |
Why?
| | Fascia | 1 | 2024 | 19 | 0.210 |
Why?
| | Sutures | 2 | 2021 | 66 | 0.200 |
Why?
| | Administration, Oral | 2 | 2025 | 867 | 0.200 |
Why?
| | Multiple Endocrine Neoplasia Type 2b | 1 | 2023 | 5 | 0.200 |
Why?
| | Multiple Endocrine Neoplasia | 1 | 2023 | 5 | 0.200 |
Why?
| | Multiple Endocrine Neoplasia Type 2a | 1 | 2023 | 14 | 0.200 |
Why?
| | Membrane Proteins | 2 | 2021 | 1130 | 0.190 |
Why?
| | Croup | 1 | 2023 | 19 | 0.190 |
Why?
| | Prospective Studies | 5 | 2025 | 8087 | 0.180 |
Why?
| | Vocal Cord Dysfunction | 1 | 2022 | 9 | 0.180 |
Why?
| | Hypoparathyroidism | 1 | 2022 | 7 | 0.180 |
Why?
| | Recurrent Laryngeal Nerve Injuries | 1 | 2022 | 16 | 0.180 |
Why?
| | Graves Disease | 1 | 2022 | 32 | 0.170 |
Why?
| | Colorado | 5 | 2020 | 4588 | 0.170 |
Why?
| | Laryngoscopes | 1 | 2022 | 45 | 0.170 |
Why?
| | Constriction, Pathologic | 4 | 2023 | 238 | 0.170 |
Why?
| | Cadherin Related Proteins | 1 | 2021 | 12 | 0.170 |
Why?
| | Nasopharynx | 1 | 2022 | 72 | 0.170 |
Why?
| | Haemophilus Infections | 1 | 2022 | 45 | 0.170 |
Why?
| | Medicine | 1 | 2023 | 126 | 0.170 |
Why?
| | Double-Blind Method | 2 | 2025 | 2064 | 0.170 |
Why?
| | Acrocephalosyndactylia | 1 | 2021 | 12 | 0.170 |
Why?
| | Nasal Obstruction | 1 | 2021 | 26 | 0.160 |
Why?
| | Job Satisfaction | 1 | 2023 | 235 | 0.160 |
Why?
| | Plasminogen | 1 | 2020 | 26 | 0.160 |
Why?
| | Nasal Septum | 1 | 2020 | 30 | 0.160 |
Why?
| | Hematoma | 1 | 2020 | 62 | 0.160 |
Why?
| | Mucolipidoses | 1 | 2020 | 9 | 0.160 |
Why?
| | Bevacizumab | 1 | 2021 | 167 | 0.150 |
Why?
| | Follow-Up Studies | 7 | 2019 | 5397 | 0.150 |
Why?
| | Bone Marrow Transplantation | 4 | 1997 | 298 | 0.150 |
Why?
| | Respiratory Tract Fistula | 1 | 2019 | 7 | 0.150 |
Why?
| | United States | 8 | 2025 | 16041 | 0.150 |
Why?
| | Tracheal Diseases | 1 | 2019 | 15 | 0.150 |
Why?
| | Cutaneous Fistula | 1 | 2019 | 17 | 0.150 |
Why?
| | Cartilage | 1 | 2021 | 197 | 0.150 |
Why?
| | Arytenoid Cartilage | 1 | 2019 | 6 | 0.150 |
Why?
| | alpha-Macroglobulins | 1 | 2019 | 24 | 0.150 |
Why?
| | Speech-Language Pathology | 1 | 2019 | 22 | 0.140 |
Why?
| | Angiogenesis Inhibitors | 1 | 2021 | 238 | 0.140 |
Why?
| | Chemoreceptor Cells | 1 | 2019 | 50 | 0.140 |
Why?
| | Laryngomalacia | 1 | 2018 | 5 | 0.140 |
Why?
| | Laryngoplasty | 1 | 2018 | 5 | 0.140 |
Why?
| | Mutation, Missense | 1 | 2020 | 331 | 0.140 |
Why?
| | Models, Organizational | 1 | 2019 | 145 | 0.140 |
Why?
| | Airway Extubation | 1 | 2019 | 60 | 0.140 |
Why?
| | Pulmonary Medicine | 1 | 2019 | 78 | 0.140 |
Why?
| | Young Adult | 9 | 2024 | 14240 | 0.140 |
Why?
| | Respiratory System | 1 | 2019 | 150 | 0.130 |
Why?
| | Respiration Disorders | 1 | 2018 | 78 | 0.130 |
Why?
| | Interdisciplinary Communication | 1 | 2019 | 200 | 0.130 |
Why?
| | Registries | 2 | 2024 | 2382 | 0.130 |
Why?
| | Vascular Diseases | 1 | 2020 | 251 | 0.130 |
Why?
| | Proton Pump Inhibitors | 1 | 2018 | 101 | 0.130 |
Why?
| | Esophageal Mucosa | 1 | 2018 | 22 | 0.130 |
Why?
| | Child Behavior | 1 | 2020 | 234 | 0.130 |
Why?
| | Severity of Illness Index | 4 | 2016 | 2910 | 0.130 |
Why?
| | Carcinoma, Medullary | 1 | 2017 | 16 | 0.130 |
Why?
| | Midazolam | 2 | 2015 | 69 | 0.130 |
Why?
| | Virtual Reality | 1 | 2019 | 82 | 0.130 |
Why?
| | Consensus | 2 | 2021 | 465 | 0.130 |
Why?
| | Betacoronavirus | 1 | 2020 | 288 | 0.120 |
Why?
| | Down-Regulation | 1 | 2019 | 612 | 0.120 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2022 | 427 | 0.120 |
Why?
| | Reoperation | 2 | 2018 | 633 | 0.120 |
Why?
| | Gastrostomy | 1 | 2018 | 123 | 0.120 |
Why?
| | Cost-Benefit Analysis | 1 | 2019 | 632 | 0.120 |
Why?
| | Sequence Analysis, DNA | 1 | 2019 | 771 | 0.120 |
Why?
| | Burnout, Professional | 1 | 2023 | 489 | 0.120 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2023 | 507 | 0.110 |
Why?
| | Neuromuscular Nondepolarizing Agents | 1 | 2015 | 34 | 0.110 |
Why?
| | Androstanols | 1 | 2015 | 30 | 0.110 |
Why?
| | Anesthetics, Intravenous | 1 | 2015 | 67 | 0.110 |
Why?
| | Genetic Predisposition to Disease | 3 | 2021 | 2455 | 0.110 |
Why?
| | Clinical Audit | 1 | 2015 | 14 | 0.110 |
Why?
| | Referral and Consultation | 2 | 2026 | 878 | 0.110 |
Why?
| | Time and Motion Studies | 1 | 2015 | 28 | 0.110 |
Why?
| | Mouth | 1 | 2015 | 84 | 0.110 |
Why?
| | Surveys and Questionnaires | 5 | 2024 | 6050 | 0.110 |
Why?
| | Esophagus | 3 | 2024 | 260 | 0.110 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 387 | 0.110 |
Why?
| | Coronavirus Infections | 1 | 2020 | 379 | 0.110 |
Why?
| | DNA, Recombinant | 1 | 2014 | 46 | 0.110 |
Why?
| | Reproducibility of Results | 3 | 2024 | 3396 | 0.110 |
Why?
| | Program Evaluation | 1 | 2019 | 945 | 0.110 |
Why?
| | Respiratory Aspiration | 1 | 2014 | 32 | 0.100 |
Why?
| | Fentanyl | 1 | 2015 | 126 | 0.100 |
Why?
| | Administration, Intranasal | 1 | 2014 | 94 | 0.100 |
Why?
| | Prognosis | 3 | 2018 | 4331 | 0.100 |
Why?
| | Survival Rate | 2 | 2018 | 2078 | 0.100 |
Why?
| | Tomography, X-Ray Computed | 3 | 2020 | 2766 | 0.100 |
Why?
| | Pedigree | 3 | 2020 | 507 | 0.100 |
Why?
| | Bronchogenic Cyst | 1 | 2013 | 8 | 0.100 |
Why?
| | Quality of Health Care | 1 | 2019 | 692 | 0.100 |
Why?
| | Iatrogenic Disease | 1 | 2014 | 73 | 0.100 |
Why?
| | Patient Outcome Assessment | 1 | 2014 | 128 | 0.100 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2013 | 81 | 0.100 |
Why?
| | Anesthetics, Local | 1 | 2014 | 106 | 0.100 |
Why?
| | Chromosome Deletion | 1 | 2013 | 126 | 0.100 |
Why?
| | Genetic Variation | 1 | 2018 | 992 | 0.100 |
Why?
| | Appointments and Schedules | 1 | 2014 | 97 | 0.100 |
Why?
| | Radiography | 1 | 2015 | 856 | 0.090 |
Why?
| | Hospitalization | 2 | 2026 | 2468 | 0.090 |
Why?
| | Pharyngitis | 1 | 2013 | 28 | 0.090 |
Why?
| | Rhinitis | 1 | 2014 | 159 | 0.090 |
Why?
| | Ambulatory Care | 1 | 2018 | 627 | 0.090 |
Why?
| | Neuralgia | 1 | 2014 | 140 | 0.090 |
Why?
| | Tetanus Antitoxin | 1 | 1992 | 2 | 0.090 |
Why?
| | Tetanus Toxoid | 1 | 1992 | 34 | 0.090 |
Why?
| | Graft Rejection | 1 | 2016 | 504 | 0.090 |
Why?
| | Antibodies | 1 | 2014 | 395 | 0.090 |
Why?
| | Fatal Outcome | 1 | 2013 | 302 | 0.090 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1790 | 0.090 |
Why?
| | Sinusitis | 1 | 2014 | 220 | 0.090 |
Why?
| | Immunization, Secondary | 1 | 1992 | 93 | 0.090 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2014 | 543 | 0.090 |
Why?
| | Mutation | 2 | 2021 | 4082 | 0.090 |
Why?
| | Academic Medical Centers | 1 | 2015 | 560 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1700 | 0.080 |
Why?
| | Asthma | 1 | 2023 | 1800 | 0.080 |
Why?
| | Patient Safety | 1 | 2015 | 351 | 0.080 |
Why?
| | Cytosine | 1 | 2011 | 49 | 0.080 |
Why?
| | Off-Label Use | 1 | 2011 | 50 | 0.080 |
Why?
| | Time Factors | 3 | 2019 | 7079 | 0.080 |
Why?
| | Ear Ossicles | 1 | 2010 | 10 | 0.080 |
Why?
| | Organophosphonates | 1 | 2011 | 95 | 0.080 |
Why?
| | Patient Readmission | 1 | 2016 | 771 | 0.080 |
Why?
| | Endoscopy, Digestive System | 2 | 2024 | 141 | 0.080 |
Why?
| | Airway Management | 1 | 2011 | 84 | 0.080 |
Why?
| | Disclosure | 1 | 2010 | 88 | 0.080 |
Why?
| | Professional Competence | 1 | 2010 | 90 | 0.080 |
Why?
| | Teratoma | 1 | 2011 | 121 | 0.070 |
Why?
| | Thyroidectomy | 2 | 2022 | 96 | 0.070 |
Why?
| | Preanesthetic Medication | 1 | 1988 | 6 | 0.070 |
Why?
| | Patient Selection | 1 | 2012 | 720 | 0.070 |
Why?
| | Anesthesia, Local | 1 | 1988 | 27 | 0.070 |
Why?
| | Communication | 1 | 2015 | 979 | 0.070 |
Why?
| | Middle Ear Ventilation | 1 | 2007 | 16 | 0.070 |
Why?
| | Audiometry | 1 | 2007 | 34 | 0.070 |
Why?
| | Mice | 6 | 2022 | 18266 | 0.070 |
Why?
| | Electronic Health Records | 1 | 2016 | 1208 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 2 | 2018 | 3917 | 0.060 |
Why?
| | Prevalence | 2 | 2020 | 2852 | 0.060 |
Why?
| | RNA, Messenger | 1 | 2014 | 2783 | 0.060 |
Why?
| | Antiviral Agents | 2 | 2011 | 774 | 0.060 |
Why?
| | Risk Factors | 3 | 2019 | 10840 | 0.060 |
Why?
| | Hematologic Diseases | 1 | 1986 | 66 | 0.060 |
Why?
| | Catheters, Indwelling | 1 | 1986 | 94 | 0.060 |
Why?
| | Head and Neck Neoplasms | 1 | 2011 | 563 | 0.060 |
Why?
| | Pilot Projects | 1 | 2010 | 1878 | 0.050 |
Why?
| | Temporal Muscle | 1 | 2024 | 3 | 0.050 |
Why?
| | Multiple Trauma | 1 | 2026 | 118 | 0.050 |
Why?
| | Practice Patterns, Physicians' | 1 | 2014 | 1370 | 0.050 |
Why?
| | Cadaver | 2 | 2019 | 302 | 0.050 |
Why?
| | Absorbable Implants | 1 | 2024 | 38 | 0.050 |
Why?
| | Polyesters | 1 | 2024 | 76 | 0.050 |
Why?
| | Observer Variation | 1 | 2024 | 355 | 0.050 |
Why?
| | Transplantation, Homologous | 4 | 2011 | 415 | 0.050 |
Why?
| | Video Recording | 1 | 2024 | 218 | 0.050 |
Why?
| | Carcinoma, Neuroendocrine | 1 | 2023 | 38 | 0.050 |
Why?
| | Hyperplasia | 1 | 2023 | 164 | 0.050 |
Why?
| | Accidental Falls | 1 | 2026 | 226 | 0.050 |
Why?
| | Animals | 6 | 2022 | 38030 | 0.050 |
Why?
| | Breathing Exercises | 1 | 2022 | 21 | 0.050 |
Why?
| | Vocal Cords | 1 | 2022 | 27 | 0.050 |
Why?
| | Cough | 1 | 2023 | 123 | 0.040 |
Why?
| | Biofeedback, Psychology | 1 | 2022 | 35 | 0.040 |
Why?
| | Haemophilus influenzae | 1 | 2022 | 67 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2023 | 424 | 0.040 |
Why?
| | Societies, Medical | 1 | 2025 | 901 | 0.040 |
Why?
| | Esophagoscopes | 1 | 2020 | 4 | 0.040 |
Why?
| | Leukemia, Myeloid, Acute | 3 | 1992 | 700 | 0.040 |
Why?
| | Nasal Cavity | 1 | 2021 | 60 | 0.040 |
Why?
| | Perioperative Period | 1 | 2020 | 69 | 0.040 |
Why?
| | Internationality | 1 | 2021 | 156 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2023 | 483 | 0.040 |
Why?
| | Philippines | 1 | 2019 | 50 | 0.040 |
Why?
| | Laryngeal Mucosa | 1 | 2019 | 5 | 0.040 |
Why?
| | Antineoplastic Agents | 1 | 2011 | 2218 | 0.040 |
Why?
| | Finland | 1 | 2019 | 72 | 0.040 |
Why?
| | Foreign Bodies | 1 | 2020 | 109 | 0.040 |
Why?
| | Pakistan | 1 | 2019 | 83 | 0.040 |
Why?
| | Single-Blind Method | 1 | 2019 | 312 | 0.040 |
Why?
| | Athletic Injuries | 1 | 2026 | 574 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2021 | 6021 | 0.040 |
Why?
| | Esophageal pH Monitoring | 1 | 2018 | 22 | 0.040 |
Why?
| | Patient Discharge | 1 | 2025 | 991 | 0.040 |
Why?
| | Social Support | 1 | 2023 | 644 | 0.040 |
Why?
| | Lung | 2 | 2023 | 4119 | 0.040 |
Why?
| | Saliva | 1 | 2020 | 256 | 0.030 |
Why?
| | Nerve Fibers | 1 | 2019 | 104 | 0.030 |
Why?
| | California | 1 | 2020 | 473 | 0.030 |
Why?
| | COS Cells | 1 | 2018 | 173 | 0.030 |
Why?
| | Clinical Protocols | 1 | 2020 | 279 | 0.030 |
Why?
| | Electric Impedance | 1 | 2018 | 108 | 0.030 |
Why?
| | Device Removal | 1 | 2019 | 149 | 0.030 |
Why?
| | Interdisciplinary Research | 1 | 2018 | 25 | 0.030 |
Why?
| | Emotions | 1 | 2023 | 555 | 0.030 |
Why?
| | Patient Reported Outcome Measures | 1 | 2022 | 502 | 0.030 |
Why?
| | Infant, Premature | 1 | 2022 | 622 | 0.030 |
Why?
| | Exome | 1 | 2018 | 232 | 0.030 |
Why?
| | Anesthetics | 1 | 2018 | 100 | 0.030 |
Why?
| | Chickenpox Vaccine | 1 | 1997 | 75 | 0.030 |
Why?
| | Transplantation, Autologous | 3 | 1992 | 303 | 0.030 |
Why?
| | Ultrasonography, Doppler | 1 | 2017 | 122 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2019 | 441 | 0.030 |
Why?
| | Caregivers | 1 | 2025 | 1079 | 0.030 |
Why?
| | Taste Buds | 1 | 2019 | 214 | 0.030 |
Why?
| | Survival Analysis | 2 | 2017 | 1372 | 0.030 |
Why?
| | Ambulatory Care Facilities | 1 | 2018 | 267 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 746 | 0.030 |
Why?
| | Patient-Centered Care | 1 | 2021 | 551 | 0.030 |
Why?
| | Recurrence | 1 | 2019 | 1125 | 0.030 |
Why?
| | Perioperative Care | 1 | 2018 | 229 | 0.030 |
Why?
| | Terminology as Topic | 1 | 2018 | 253 | 0.030 |
Why?
| | Comorbidity | 1 | 2020 | 1652 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2017 | 503 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2017 | 777 | 0.030 |
Why?
| | Age Factors | 2 | 2014 | 3321 | 0.030 |
Why?
| | Health Services Research | 1 | 2018 | 389 | 0.030 |
Why?
| | Tongue | 1 | 2015 | 73 | 0.030 |
Why?
| | Hypertrophy | 1 | 2015 | 126 | 0.030 |
Why?
| | Adolescent Behavior | 1 | 2020 | 486 | 0.030 |
Why?
| | Genomics | 1 | 2020 | 851 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2019 | 1709 | 0.030 |
Why?
| | Disease Management | 1 | 2019 | 649 | 0.030 |
Why?
| | Long-Term Care | 1 | 2015 | 116 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2019 | 1125 | 0.030 |
Why?
| | Transcriptome | 1 | 2021 | 1066 | 0.030 |
Why?
| | Benzofurans | 1 | 2014 | 26 | 0.030 |
Why?
| | Pain Threshold | 1 | 2014 | 72 | 0.030 |
Why?
| | TRPV Cation Channels | 1 | 2014 | 43 | 0.030 |
Why?
| | Neural Conduction | 1 | 2014 | 92 | 0.030 |
Why?
| | Adult | 6 | 2023 | 40821 | 0.030 |
Why?
| | Ganglia, Spinal | 1 | 2014 | 88 | 0.030 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2020 | 700 | 0.030 |
Why?
| | Sensory Receptor Cells | 1 | 2014 | 98 | 0.020 |
Why?
| | Hyperalgesia | 1 | 2014 | 127 | 0.020 |
Why?
| | Thoracotomy | 1 | 2013 | 87 | 0.020 |
Why?
| | Rats, Wistar | 1 | 2014 | 449 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2017 | 1486 | 0.020 |
Why?
| | Quinolines | 1 | 2014 | 191 | 0.020 |
Why?
| | Fetal Therapies | 1 | 2013 | 48 | 0.020 |
Why?
| | Cell Line | 1 | 2018 | 2809 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2228 | 0.020 |
Why?
| | Tetanus | 1 | 1992 | 29 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2020 | 3005 | 0.020 |
Why?
| | Anemia, Aplastic | 1 | 1992 | 42 | 0.020 |
Why?
| | Early Detection of Cancer | 1 | 2017 | 501 | 0.020 |
Why?
| | Endoscopy | 1 | 2014 | 316 | 0.020 |
Why?
| | Pain Measurement | 1 | 2014 | 567 | 0.020 |
Why?
| | Ultrasonography, Prenatal | 1 | 2013 | 291 | 0.020 |
Why?
| | Injections, Intralesional | 1 | 2011 | 34 | 0.020 |
Why?
| | Cohort Studies | 1 | 2022 | 6045 | 0.020 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2015 | 300 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2014 | 820 | 0.020 |
Why?
| | Malleus | 1 | 2010 | 1 | 0.020 |
Why?
| | Incus | 1 | 2010 | 6 | 0.020 |
Why?
| | Neoplasms | 1 | 1986 | 2944 | 0.020 |
Why?
| | Incidence | 1 | 2017 | 2910 | 0.020 |
Why?
| | Stapes | 1 | 2010 | 22 | 0.020 |
Why?
| | Aerosols | 1 | 2011 | 146 | 0.020 |
Why?
| | Temporal Bone | 1 | 2010 | 43 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2019 | 2591 | 0.020 |
Why?
| | Inflammation | 1 | 2021 | 2915 | 0.020 |
Why?
| | Graft vs Host Disease | 1 | 1992 | 280 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2011 | 567 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2014 | 2131 | 0.020 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1992 | 299 | 0.020 |
Why?
| | Graft Survival | 1 | 2011 | 508 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2010 | 1041 | 0.020 |
Why?
| | Flunitrazepam | 1 | 1988 | 3 | 0.020 |
Why?
| | Chronic Disease | 1 | 2014 | 1824 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2011 | 1531 | 0.020 |
Why?
| | Random Allocation | 1 | 1988 | 365 | 0.020 |
Why?
| | Morphine | 1 | 1988 | 169 | 0.020 |
Why?
| | Stents | 1 | 2011 | 551 | 0.020 |
Why?
| | Imaging, Three-Dimensional | 1 | 2010 | 578 | 0.010 |
Why?
| | Ultrasonography | 1 | 2010 | 788 | 0.010 |
Why?
| | Logistic Models | 1 | 2011 | 2112 | 0.010 |
Why?
| | Rats | 1 | 2014 | 5574 | 0.010 |
Why?
| | Signal Transduction | 1 | 2019 | 5234 | 0.010 |
Why?
| | Heart Atria | 1 | 1986 | 139 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2015 | 5875 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2014 | 4565 | 0.010 |
Why?
| | Anti-Bacterial Agents | 1 | 2014 | 1935 | 0.010 |
Why?
| | Middle Aged | 4 | 2019 | 36359 | 0.010 |
Why?
| | Clinical Trials as Topic | 1 | 1988 | 1062 | 0.010 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 1991 | 1996 | 0.010 |
Why?
| | Pancreatic Function Tests | 1 | 1981 | 4 | 0.010 |
Why?
| | Exocrine Pancreatic Insufficiency | 1 | 1981 | 25 | 0.010 |
Why?
| | Pregnancy | 1 | 2013 | 7217 | 0.010 |
Why?
| | Somatostatin | 1 | 1980 | 54 | 0.010 |
Why?
| | Dietary Fats | 1 | 1980 | 307 | 0.010 |
Why?
| | Bromodeoxyuridine | 1 | 1997 | 74 | 0.010 |
Why?
| | Triglycerides | 1 | 1980 | 527 | 0.010 |
Why?
| | Chickenpox | 1 | 1997 | 83 | 0.010 |
Why?
| | Immune Tolerance | 1 | 1997 | 384 | 0.010 |
Why?
| | Herpes Zoster | 1 | 1997 | 318 | 0.010 |
Why?
| | Antibodies, Viral | 1 | 1997 | 683 | 0.010 |
Why?
| | Immunoglobulin G | 1 | 1997 | 899 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 1997 | 2018 | 0.010 |
Why?
| | Bone Marrow Purging | 1 | 1991 | 3 | 0.010 |
Why?
| | Daunorubicin | 1 | 1991 | 25 | 0.010 |
Why?
| | Thioguanine | 1 | 1991 | 18 | 0.010 |
Why?
| | Cytarabine | 1 | 1991 | 66 | 0.010 |
Why?
| | Leukocyte Count | 1 | 1992 | 319 | 0.010 |
Why?
| | Remission Induction | 1 | 1992 | 308 | 0.010 |
Why?
| | Vaccination | 1 | 1997 | 1444 | 0.000 |
Why?
| | Combined Modality Therapy | 1 | 1991 | 1269 | 0.000 |
Why?
| | Aged | 1 | 1988 | 26251 | 0.000 |
Why?
| | Fluoresceins | 1 | 1981 | 48 | 0.000 |
Why?
| | Lipase | 1 | 1980 | 76 | 0.000 |
Why?
| | Fatty Acids, Nonesterified | 1 | 1980 | 154 | 0.000 |
Why?
| | Cholesterol | 1 | 1980 | 410 | 0.000 |
Why?
| | Blood Glucose | 1 | 1980 | 2357 | 0.000 |
Why?
| | Insulin | 1 | 1980 | 2524 | 0.000 |
Why?
|
|
Prager's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|